Abstract
To review the treatments currently used to treat mycobacteria (latent tuberculosis, clinical tuberculosis, infections due to mycobacteria), focussing on : Doses administered and duration of treatment Levels reached in different body tissues in relation to the chemical characteristics of the drugs The relation between these data and the microbiological parameters of each microorganism To review the above parameters for the new groups of drugs being investigated for treatment of the three pathologies. a. fluorquinolones b. macrolides c. rifampicins d. oxazolidinones e. tetracyclines f.- other drugs undergoing investigation
Keywords: Mycobacterium tuberculosis, rifampicin resistance, fluoroquinolones, Mycobacterium avium, M-DCMG conjugate
Anti-Infective Agents in Medicinal Chemistry
Title: Present and Future Treatment of Mycobacteria
Volume: 7 Issue: 1
Author(s): J. C. Rodriguez, I. Escribano, R. A. Gomez, E. Garcia Pachon, A. Navarro and G. Royo
Affiliation:
Keywords: Mycobacterium tuberculosis, rifampicin resistance, fluoroquinolones, Mycobacterium avium, M-DCMG conjugate
Abstract: To review the treatments currently used to treat mycobacteria (latent tuberculosis, clinical tuberculosis, infections due to mycobacteria), focussing on : Doses administered and duration of treatment Levels reached in different body tissues in relation to the chemical characteristics of the drugs The relation between these data and the microbiological parameters of each microorganism To review the above parameters for the new groups of drugs being investigated for treatment of the three pathologies. a. fluorquinolones b. macrolides c. rifampicins d. oxazolidinones e. tetracyclines f.- other drugs undergoing investigation
Export Options
About this article
Cite this article as:
Rodriguez C. J., Escribano I., Gomez A. R., Pachon Garcia E., Navarro A. and Royo G., Present and Future Treatment of Mycobacteria, Anti-Infective Agents in Medicinal Chemistry 2008; 7 (1) . https://dx.doi.org/10.2174/187152108783329816
DOI https://dx.doi.org/10.2174/187152108783329816 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
Reversal of Tumor Induced Dendritic Cell Paralysis: A Treatment Regimen Against Cancer
Current Immunology Reviews (Discontinued) Synthesis, Biological Profile, and Molecular Docking of Some New Bis- Imidazole Fused Templates and Investigation of their Cytotoxic Potential as Anti-tubercular and/or Anticancer Prototypes
Medicinal Chemistry Selection of Targets for Drug Development Against Protozoan Parasites
Current Drug Targets Bridged Piperazines and Piperidines as CCR1 Antagonists with Oral Activity in Models of Arthritis and Multiple Sclerosis
Letters in Drug Design & Discovery Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 2: Calciferol and the Significance of Nutrient Supplements
Inflammation & Allergy - Drug Targets (Discontinued) Cross-Talk Between Mesenchymal Stem/Stromal Cells and Dendritic Cells
Current Stem Cell Research & Therapy Graphical Abstracts
Letters in Drug Design & Discovery QSAR Study of Androstenedione Analogs as Aromatase Inhibitors
Letters in Drug Design & Discovery Development and Characterization of Spray Dried Microparticles for Pulmonary Delivery of Antifungal Drug
Current Drug Delivery Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.
Anti-Infective Agents in Medicinal Chemistry Nutraceuticals, A New Challenge for Medicinal Chemistry
Current Medicinal Chemistry Therapeutic Potentials of Scavenger Receptor CD36 Mediated Innate Immune Responses Against Infectious and Non-Infectious Diseases
Current Drug Discovery Technologies Current Understanding of the Role of Dendritic Cells and Their Co-Stimulatory Molecules in Generating Efficient T Cell Responses in Lepromatous Leprosy
Current Immunology Reviews (Discontinued) Novel Electrochemical Sensor for Rifampicin based on Ionic Liquid Functionalised TiO2 Nanoparticles
Current Analytical Chemistry Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies
Current Drug Targets Synthesis, Characterization, Antimycobacterial and Anticancer Evaluation of New 1,2,4-Triazole Derivatives
Letters in Drug Design & Discovery Editorial (Thematic Issue: Molecular Determinants of Bacterial Diseases)
Current Medicinal Chemistry The Role of Bacterial Lipopolysaccharides as Immune Modulator in Vaccine and Drug Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Vitamin D: Evolutionary, Physiological and Health Perspectives
Current Drug Targets Renal Cell Carcinoma in a Patient with Rheumatoid Arthritis Treated with Adalimumab
Current Drug Safety